Radiopharm Theranostics Limited (AU:RAD) has released an update.
Radiopharm Theranostics, a clinical stage company specializing in radiopharmaceuticals, will be featured in a series of healthcare events by B. Riley Securities, focusing on their diagnostic and therapeutic technologies. The events, aimed at US investors, will include presentations and a panel discussion on brain tumors, highlighting the company’s strong position in the radiopharmaceutical industry. Radiopharm’s pipeline includes advanced trials in several solid tumor cancers, reflecting their potential as an emerging leader in this medical sector.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.
